Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?
Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?, Published online: 26 April 2018; doi:10.1038/s41409-018-0191-8Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?
Source: Bone Marrow Transplantation - Category: Hematology Authors: Carlos Solano Alberto Talaya Estela Gim énez Eliseo Albert Jos é Luis Piñana Juan Carlos Hern ández-Boluda Ariadna P érez David Navarro Source Type: research
More News: Bone Marrow Transplant | Cytomegalovirus | Hematology | Stem Cell Therapy | Stem Cells | Transplants